Medartis Ag logo

Medartis Ag(XSWX) MED

Market CapCHF 1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+33%
5 Year-23%
1 Year-0%
1 Month-1%
CHF 84.10
+2.31%
+1.90Today
Medartis Ag last closing stock price
MetricPriceDate
Last closeCHF 82.202026-10-13
Medartis Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.72%CHF 82.802026-10-06
1 month-1.44%CHF 83.402026-09-11
3 month-10.75%CHF 92.102026-07-15
Year to date-6.8%CHF 88.202025-12-30
1 year-0.24%CHF 82.402025-10-13
3 year+1.61%CHF 80.902023-10-13
5 year-23.46%CHF 107.402021-10-14
Since inception+32.67%CHF 61.962018-03-23

Medartis Ag Financials at a Glance

Market Cap

CHF 1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$316.93M

Net Income (TTM)

-$25.60M

EPS (TTM)

CHF 1.20

P/E Ratio

68.49

Dividend

CHF 0.00

Beta (Volatility)

-0.04 (Low)

Price

CHF 84.10

Volume

29,635

Open

CHF 83.20

Previous Close

CHF 82.20

Daily Range

CHF 83.00 - CHF 84.10

52-Week Range

CHF 70.60 - CHF 97.50

Estimated Earnings Date

Nov 9, 2026

MED News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medartis Ag

Medifast, Inc. is a leading provider of health and nutritional products focused on weight loss, weight management, and overall wellness. Established in 1980 and headquartered in Baltimore, Maryland, the company offers a diverse range of consumable items marketed under proprietary brands such as OPTAVIA and Optimal Health by Take Shape for Life.

Products and Services
  • Wide range of health and nutritional products including snack bars and shakes
  • Specialized meal plans tailored for weight management and wellness
  • Direct e-commerce sales model for customer convenience
Growth Outlook
  • Recent quarterly revenue of $76.38 million shows consistent demand
  • Strong gross profit margin of 69.9% indicates effective cost management
  • Cash and short-term investments total $169.82 million, providing financial flexibility
Financial Highlights
  • Trailing twelve months revenue of $303.5 million reflects stable performance
  • Current ratio of 4.86 suggests strong liquidity position
  • Net income for Q2 2026 was -$3.1 million, indicating ongoing challenges
Medifast, Inc. operates in the personal products and services industry, focusing on health and wellness solutions. The company has established a strong market presence through its innovative product offerings and direct-to-consumer sales approach. Despite facing recent financial challenges, the company maintains a solid liquidity position, which may support future growth initiatives. The recent quarterly revenue figures indicate a steady demand for its products, while the gross profit margin reflects effective cost management strategies. Investors may find the company's extensive cash reserves and diverse product portfolio appealing as it navigates the competitive landscape of the health and wellness sector.
AI Generated • Sep 21, 2026

Industry

Healthcare Equipment and Supplies

Employees

1,337

CEO

Matthias Schupp

Headquarters

Baltimore, MD 21224, US

MED Financials

Key Financial Metrics (TTM)

Gross Margin

69.24%

Operating Margin

-5.46%

Net Income Margin

-8.08%

Return on Equity

-12.68%

Return on Capital

-6.59%

Return on Assets

-9.83%

Earnings Yield

1.46%

Dividend Yield

0.00%

Payout Ratio

-0.66%

Stock Overview

Market Cap

CHF 1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.45M

Volume

29.64K

Avg. Volume

7.76K

Financials (TTM)

Gross Profit

$219.45M

Operating Income

-$17.31M

EBITDA

-$125.00K

Operating Cash Flow

$8.79M

Capital Expenditure

-$4.78M

Free Cash Flow

$4.01M

Cash & ST Invst.

$169.82M

Total Debt

$27.62M

Medartis Ag Performance Analysis

Medartis Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 182,824,41814.4%
20232023-12-31USD 212,006,00016.0%
20242024-12-31USD 224,831,0006.0%
20252025-12-31USD 269,257,00019.8%
Medartis Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-15.3%
Q42025-12-31-16.0%
Q12026-03-311.3%
Q22026-06-300.4%
Medartis Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.49N/A
20232023-12-31USD 0.05N/A
20242024-12-31USD 0.28462.1%
20252025-12-31USD 0.67135.9%
Medartis Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-195.5%
Q42025-12-31-685.7%
Q12026-03-3188.5%
Q22026-06-30-47.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$76.38M

-27.6%

Gross Profit

$53.40M

-30.3%

Gross Margin

69.90%

N/A

Market Cap

CHF 1.02BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CHF 2.69M

N/A

Employees

380

N/A

Net Income

-$3.10M

-225.0%

EBITDA

$455.00K

-93.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$169.82M

+4.4%

Total Debt

$27.62M

+111.3%

Accounts Receivable

$0.00

N/A

Inventory

$21.18M

-29.9%

Long Term Debt

$22.46M

+214.4%

Short Term Debt

$5.16M

-12.9%

Return on Assets

-9.83%

N/A

Return on Invested Capital

-7.91%

N/A

Free Cash Flow

$728.00K

+115.3%

Operating Cash Flow

$1.70M

+150.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CURVTorrid Holdings Inc.
$2.36-0.21%
BSETBassett Furniture Industries, Incorporated
$21.46+1.10%
CLARClarus Corporation
$3.50-1.13%
CAASChina Automotive Systems, Inc.
$4.43+0.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
BACBank of America
$51.05-5.40%
CRWVCoreWeave
$65.46-15.87%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$42.27+12.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$111.28-12.77%

Questions About MED

What is the current price of Medartis Ag?

Medartis Ag is trading at CHF 84.10 per share.

What is the 52-week range for Medartis Ag?

Over the past 52 weeks, Medartis Ag has traded between CHF 70.60 and CHF 97.50.

How much debt does Medartis Ag have?

As of the most recent reporting period, Medartis Ag reported total debt of $158.12M.

How much cash does Medartis Ag have on hand?

Medartis Ag reported $32.97M in cash and cash equivalents in its most recent financial results.

What is Medartis Ag’s dividend yield?

Medartis Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.